Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen Inc. | -0.36% | 356.83 | 1.2% | $818.26m | |
| AMGN | Amgen Inc. | -1.01% | 189.83 | 1.2% | $543.35m | |
| CELG | Celgene Corporation | -0.36% | 85.03 | 1.2% | $517.56m | |
| GILD | Gilead Sciences, Inc. | -0.07% | 77.00 | 0.9% | $473.15m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.16% | 178.03 | 1.9% | $311.89m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.36% | 366.41 | 2.6% | $283.41m | |
| ILMN | Illumina, Inc. | 0.44% | 310.46 | 3.5% | $265.60m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.45% | 134.92 | 16.6% | $231.08m | |
| BLUE | Bluebird Bio, Inc. | 0.96% | 180.68 | 15.7% | $203.89m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.02% | 135.07 | 2.0% | $176.52m | |
| NKTR | Nektar Therapeutics | -1.41% | 48.39 | 5.6% | $171.62m | |
| EXAS | Exact Sciences Corporation | 0.34% | 67.84 | 25.4% | $159.30m | |
| EXEL | Exelixis, Inc. | -0.56% | 21.22 | 6.4% | $135.63m | |
| BMRN | BioMarin Pharmaceutical Inc. | -1.03% | 101.81 | 4.4% | $123.85m | |
| A | Agilent Technologies, Inc. | 0.07% | 64.20 | 1.5% | $122.71m |
Company Profile
T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection including one colony forming unit per milliliter. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.